{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:56:28Z","timestamp":1790744188390,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"vor","delay-in-days":372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012247","name":"Program of Shanghai Academic Research Leader","doi-asserted-by":"publisher","award":["20XD1422700"],"award-info":[{"award-number":["20XD1422700"]}],"id":[{"id":"10.13039\/501100012247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFA0506200"],"award-info":[{"award-number":["2017YFA0506200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2018CR006"],"award-info":[{"award-number":["2018CR006"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81861130368"],"award-info":[{"award-number":["81861130368"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073292"],"award-info":[{"award-number":["82073292"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81622002"],"award-info":[{"award-number":["81622002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003395","name":"Shanghai Municipal Education Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009729","name":"Ludwig Institute for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009729","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ccell.2020.11.013","type":"journal-article","created":{"date-parts":[[2020,12,24]],"date-time":"2020-12-24T17:19:11Z","timestamp":1608830351000},"page":"225-239.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":240,"title":["Arsenic Trioxide Rescues Structural p53 Mutations through a Cryptic Allosteric Site"],"prefix":"10.1016","volume":"39","author":[{"given":"Shuo","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Le","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Gang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Xin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Li","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Fei","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Tong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Jun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai-Juan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6902-3751","authenticated-orcid":false,"given":"Min","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2020.11.013_bib1","doi-asserted-by":"crossref","first-page":"10360","DOI":"10.1073\/pnas.0805326105","article-title":"Targeted rescue of a destabilized mutant of p53 by an in\u00a0silico screened drug","volume":"105","author":"Boeckler","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ccell.2020.11.013_bib2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/35094077","article-title":"Rescuing the function of mutant p53","volume":"1","author":"Bullock","year":"2001","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2020.11.013_bib3","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/sj.onc.1203434","article-title":"Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy","volume":"19","author":"Bullock","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.ccell.2020.11.013_bib4","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nm0302-282","article-title":"Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound","volume":"8","author":"Bykov","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2020.11.013_bib5","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1038\/sj.onc.1208419","article-title":"PRIMA-1(MET) synergizes with cisplatin to induce tumor cell apoptosis","volume":"24","author":"Bykov","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.ccell.2020.11.013_bib6","first-page":"3345","article-title":"Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells","volume":"89","author":"Chen","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2020.11.013_bib7","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1182\/blood.V88.3.1052.1052","article-title":"In\u00a0vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: as2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha\/PML proteins","volume":"88","author":"Chen","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2020.11.013_bib8","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.devcel.2011.09.007","article-title":"Structural and functional studies of LRP6 Ectodomain reveal a Platform for Wnt signaling","volume":"21","author":"Chen","year":"2011","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ccell.2020.11.013_bib9","doi-asserted-by":"crossref","first-page":"17470","DOI":"10.1073\/pnas.1909393116","article-title":"iASPP mediates p53 selectivity through a modular mechanism fine-tuning DNA recognition","volume":"116","author":"Chen","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ccell.2020.11.013_bib10","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1126\/science.8023157","article-title":"Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations","volume":"265","author":"Cho","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.ccell.2020.11.013_bib11","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ccell.2017.10.002","article-title":"Acute promyelocytic leukemia: a paradigm for oncoprotein-targeted cure","volume":"32","author":"de The","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2020.11.013_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2020.11.013_bib13","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ccell.2020.11.013_bib14","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1038\/onc.2016.502","article-title":"Census and evaluation of p53 target genes","volume":"36","author":"Fischer","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.ccell.2020.11.013_bib15","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1073\/pnas.90.8.3319","article-title":"The p53 protein is an unusually shaped tetramer that binds directly to DNA","volume":"90","author":"Friedman","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ccell.2020.11.013_bib16","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/j.1460-2075.1990.tb08279.x","article-title":"Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form","volume":"9","author":"Gannon","year":"1990","journal-title":"EMBO J."},{"key":"10.1016\/j.ccell.2020.11.013_bib17","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1073\/pnas.0813280106","article-title":"Long-term efficacy and safety of all-trans retinoic acid\/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia","volume":"106","author":"Hu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ccell.2020.11.013_bib18","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s12935-020-01341-5","article-title":"Arsenic trioxide potentiates Gilteritinib-induced apoptosis in FLT3-ITD positive leukemic cells via IRE1a-JNK-mediated endoplasmic reticulum stress","volume":"20","author":"Hu","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ccell.2020.11.013_bib19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0300-483X(99)00068-2","article-title":"Strain-dependent disposition of inorganic arsenic in the mouse","volume":"137","author":"Hughes","year":"1999","journal-title":"Toxicology"},{"key":"10.1016\/j.ccell.2020.11.013_bib20","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1182\/blood.V97.1.264","article-title":"Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in\u00a0vitro and in\u00a0vivo","volume":"97","author":"Jing","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2020.11.013_bib21","doi-asserted-by":"crossref","first-page":"15056","DOI":"10.1073\/pnas.0607286103","article-title":"Structural basis for understanding oncogenic p53 mutations and designing rescue drugs","volume":"103","author":"Joerger","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ccell.2020.11.013_bib22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1146\/annurev.biochem.77.060806.091238","article-title":"Structural biology of the tumor suppressor p53","volume":"77","author":"Joerger","year":"2008","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ccell.2020.11.013_bib23","doi-asserted-by":"crossref","first-page":"a000919","DOI":"10.1101\/cshperspect.a000919","article-title":"The tumor suppressor p53: from structures to drug discovery","volume":"2","author":"Joerger","year":"2010","journal-title":"Cold Spring Harb Perspect. Biol."},{"key":"10.1016\/j.ccell.2020.11.013_bib24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev-biochem-060815-014710","article-title":"The p53 pathway: origins, inactivation in cancer, and emerging therapeutic approaches","volume":"85","author":"Joerger","year":"2016","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ccell.2020.11.013_bib25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","article-title":"Xds","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ccell.2020.11.013_bib26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2020.11.013_bib27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/jbt.20108","article-title":"Dissociation of arsenite-peptide complexes: triphasic nature, rate constants, half-lives, and biological importance","volume":"20","author":"Kitchin","year":"2006","journal-title":"J.\u00a0Biochem. Mol. Toxicol."},{"key":"10.1016\/j.ccell.2020.11.013_bib28","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1107\/S0907444904026460","article-title":"Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions","volume":"60","author":"Krissinel","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ccell.2020.11.013_bib29","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1084\/jem.189.7.1043","article-title":"Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia","volume":"189","author":"Lallemand-Breitenbach","year":"1999","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2020.11.013_bib30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev-cancerbio-030518-055455","article-title":"Targeting therapies for the p53 protein in cancer treatments","volume":"3","author":"Levine","year":"2019","journal-title":"Annu. Rev. Cancer Biol."},{"key":"10.1016\/j.ccell.2020.11.013_bib31","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1182\/blood-2002-10-3231","article-title":"Arsenic trioxide-induced apoptosis in myeloma cells: p53-dependent G1 or G2\/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2\/TRAIL","volume":"101","author":"Liu","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2020.11.013_bib32","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ccr.2013.03.013","article-title":"Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1\/CDK1-phosphorylated nuclear iASPP","volume":"23","author":"Lu","year":"2013","journal-title":"Cancer cell"},{"key":"10.1016\/j.ccell.2020.11.013_bib33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads.","volume":"17","author":"Martin","year":"2011","journal-title":"J.\u00a0EMBnet"},{"key":"10.1016\/j.ccell.2020.11.013_bib34","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J.\u00a0Appl. Crystallogr."},{"key":"10.1016\/j.ccell.2020.11.013_bib36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.etap.2004.05.008","article-title":"Arsenic antagonism studies with monoisoamyl DMSA and zinc in male mice","volume":"19","author":"Modi","year":"2005","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.ccell.2020.11.013_bib37","doi-asserted-by":"crossref","first-page":"14675","DOI":"10.1073\/pnas.95.25.14675","article-title":"Semirational design of active tumor suppressor p53 DNA binding domain with enhanced stability","volume":"95","author":"Nikolova","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ccell.2020.11.013_bib38","doi-asserted-by":"crossref","first-page":"a001008","DOI":"10.1101\/cshperspect.a001008","article-title":"TP53 mutations in human cancers: origins, consequences, and clinical use","volume":"2","author":"Olivier","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.ccell.2020.11.013_bib39","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1038\/emboj.2011.127","article-title":"An induced fit mechanism regulates p53 DNA binding kinetics to confer sequence specificity","volume":"30","author":"Petty","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.ccell.2020.11.013_bib40","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1158\/0008-5472.CAN-12-1370","article-title":"CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set","volume":"72","author":"Reinhold","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2020.11.013_bib41","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ccell.2020.11.013_bib42","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrc1951","article-title":"The NCI60 human tumour cell line anticancer drug screen","volume":"6","author":"Shoemaker","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2020.11.013_bib43","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jmb.2008.10.063","article-title":"Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations","volume":"385","author":"Suad","year":"2009","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ccell.2020.11.013_bib44","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1107\/S0907444904023510","article-title":"REFMAC5 dictionary: organization of prior chemical knowledge and guidelines for its use","volume":"60","author":"Vagin","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ccell.2020.11.013_bib45","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1126\/science.1092472","article-title":"In\u00a0vivo activation of the p53 pathway by small-molecule antagonists of MDM2","volume":"303","author":"Vassilev","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.ccell.2020.11.013_bib46","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1002\/cncr.29456","article-title":"Randomized clinical control study of locoregional therapy combined with arsenic trioxide for the treatment of hepatocellular carcinoma","volume":"121","author":"Wang","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.ccell.2020.11.013_bib47","doi-asserted-by":"crossref","first-page":"109609","DOI":"10.18632\/oncotarget.22757","article-title":"The synergistic antitumor effect of arsenic trioxide combined with cytotoxic T\u00a0cells in pulmonary metastasis model of colon cancer","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ccell.2020.11.013_bib48","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1038\/sj.onc.1204316","article-title":"The 'wildtype' conformation of p53: epitope mapping using hybrid proteins","volume":"20","author":"Wang","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.ccell.2020.11.013_bib49","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/leu.2012.180","article-title":"Downregulation of Mcl-1 through GSK-3beta activation contributes to arsenic trioxide-induced apoptosis in acute myeloid leukemia cells","volume":"27","author":"Wang","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.ccell.2020.11.013_bib50","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1182\/blood-2007-07-102798","article-title":"Acute promyelocytic leukemia: from highly fatal to highly curable","volume":"111","author":"Wang","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2020.11.013_bib51","doi-asserted-by":"crossref","first-page":"13584","DOI":"10.1073\/pnas.1211550109","article-title":"Kinetic mechanism of p53 oncogenic mutant aggregation and its inhibition","volume":"109","author":"Wilcken","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ccell.2020.11.013_bib52","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/pro.3330","article-title":"MolProbity: more and better reference data for improved all-atom structure validation","volume":"27","author":"Williams","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.ccell.2020.11.013_bib53","doi-asserted-by":"crossref","first-page":"8438","DOI":"10.1073\/pnas.96.15.8438","article-title":"Hot-spot mutants of p53 core domain evince characteristic local structural changes","volume":"96","author":"Wong","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ccell.2020.11.013_bib54","doi-asserted-by":"crossref","first-page":"e103497","DOI":"10.1371\/journal.pone.0103497","article-title":"Arsenic trioxide reactivates proteasome-dependent degradation of mutant p53 protein in cancer cells in part via enhanced expression of Pirh2 E3 ligase","volume":"9","author":"Yan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ccell.2020.11.013_bib55","doi-asserted-by":"crossref","first-page":"17478","DOI":"10.1074\/jbc.M111.231639","article-title":"Mutant p53 protein is targeted by arsenic for degradation and plays a role in arsenic-mediated growth suppression","volume":"286","author":"Yan","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccell.2020.11.013_bib56","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1158\/0008-5472.CAN-1305-2","article-title":"Ser392 phosphorylation regulates the oncogenic function of mutant p53","volume":"64","author":"Yap","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2020.11.013_bib57","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.ccr.2012.03.042","article-title":"Allele-specific p53 mutant reactivation","volume":"21","author":"Yu","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2020.11.013_bib58","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2020.11.013_bib59","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41419-018-0463-7","article-title":"APR-246 reactivates mutant p53 by targeting cysteines 124 and 277","volume":"9","author":"Zhang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ccell.2020.11.013_bib60","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1126\/science.1183424","article-title":"Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML","volume":"328","author":"Zhang","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ccell.2020.11.013_bib61","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1200\/JCO.2013.48.8312","article-title":"Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial","volume":"31","author":"Zhu","year":"2013","journal-title":"J.\u00a0Clin. Oncol."}],"updated-by":[{"DOI":"10.1016\/j.ccell.2025.07.020","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000}}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153561082030605X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153561082030605X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:04:27Z","timestamp":1761523467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153561082030605X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S153561082030605X"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2020.11.013","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.739268544.793582908","asserted-by":"object"}]},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Arsenic Trioxide Rescues Structural p53 Mutations through a Cryptic Allosteric Site","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2020.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}